Stockreport

Seneca Biopharma, Inc. Announces the Completion of Stem Cell Manufacturing Facility in China

Seneca Biopharma, Inc.  (SNCA) 
PDF GERMANTOWN, Md., April 3, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of [Read more]